Dr. Kvols is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
12902 Usf Magnolia Dr
Tampa, FL 33612Phone+1 813-903-3519Fax+1 813-745-7229
Education & Training
- National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1973 - 1975
- Johns Hopkins UniversityResidency, Internal Medicine, 1970 - 1973
- Baylor College of MedicineClass of 1970
Certifications & Licensure
- FL State Medical License 2002 - 2015
Clinical Trials
- Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer Start of enrollment: 1998 Jan 01
- Radiolabeled SMT-487 (Yttrium Y 90-DOTA-tyr3-octreotide) in Treating Patients With Refractory Small Cell Lung Cancer or Metastatic Breast Cancer Start of enrollment: 2000 Jul 01
- Avastin, Fluorouracil, Doxorubicin and Streptozocin in Locally Advanced and Metastatic Pancreatic Endocrine Tumors Start of enrollment: 2007 Aug 01
Publications & Presentations
PubMed
- 25 citationsMultimodality Management of "Borderline Resectable" Pancreatic Neuroendocrine Tumors: Report of a Single-Institution Experience.Chenwi Ambe, Phuong Nguyen, Barbara A. Centeno, Junsung Choi, Jonathan R. Strosberg
Cancer Control. 2017-09-14 - 32 citationsImpact of Previous Somatostatin Analogue Use on the Activity of Everolimus in Patients with Advanced Neuroendocrine Tumors: Analysis from the Phase III RADIANT-2 Trial.Lowell B. Anthony, Marianne Pavel, John D. Hainsworth, Larry K. Kvols, Scott Segal
Neuroendocrinology. 2015-09-24 - ENETS News LetterAlan R. Gintzler, Arjun Kumar, Nai-Jiang Liu, Zsolt Liposits, Csaba Vastagh
Neuroendocrinology. 2015-01-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: